Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DaBomb Protein Biotech Corp. (6578:TWSE), powered by AI.
DaBomb Protein Biotech Corp. is currently trading at $16.55. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for DaBomb Protein Biotech Corp. on Alpha Lenz.
View DaBomb Protein Biotech Corp.'s valuation metrics on Alpha Lenz.
“DaBomb Protein Biotech Corp.'s ROE is -6.7%. Explore profitability and growth together.”
Ask for details →DaBomb Protein Biotech Corp. is a biotechnology and food processing company based in Tainan, Taiwan. The company specializes in the manufacture and development of hydrolyzed soybean peptide protein, functional peptides, and alternative solutions to antibiotics for the animal health industry. Its product portfolio serves diverse markets, including feed manufacturers, livestock and aquaculture operators, and pet health sectors, with offerings that range from high-purity plant proteins to innovative postbiotic and fermentation-based health products. DaBomb Protein Biotech Corp. emphasizes natural, eco-friendly, and safe solutions by utilizing advanced fermentation and postbiotic technologies to enhance protein utility and immune support. Since its founding in 2001, the company has built a strong presence in the Asia-Pacific region and supplies its ingredients to sectors engaged in animal nutrition and functional foods, underscoring its role as a pioneer in sustainable protein production and antibiotic replacement technologies.
“DaBomb Protein Biotech Corp.'s ROE is -6.7%. Explore profitability and growth together.”
Ask for details →DaBomb Protein Biotech Corp. (ticker: 6578) is a company listed on TWSE in the Consumer Defensive sector (Packaged Foods).
The current price is 16.55 with a P/E ratio of -x and P/B of -x.
ROE is -6.67% and operating margin is -9.11%. Annual revenue is $309M.